Astellas and Potenza partner in immuno- oncology
This article was originally published in Scrip
Executive Summary
Japan's Astellas is hoping to shore up its oncology offerings by developing and delivering second-generation immune-oncology therapies through a partnership with Cambridge, Massachusetts-based Potenza.